Request Demo
Last update 08 May 2025
Nanjing Kanghai Phospholipid Biological Technology Co., Ltd.
Subsidiary Company|2010|Jiangsu Sheng, China
Subsidiary Company|2010|Jiangsu Sheng, China
Last update 08 May 2025
Overview
Tags
Respiratory Diseases
Neoplasms
Skin and Musculoskeletal Diseases
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20182328
在晚期实体瘤患者中口服LPM3480226片的安全及耐受性、药代及药效动力学特征的非随机、开放、剂量递增的1期临床
[Translation] A non-randomized, open-label, dose-escalation phase 1 clinical trial evaluating the safety and tolerability, pharmacokinetics, and pharmacodynamics of oral LPM3480226 tablets in patients with advanced solid tumors.
100 Clinical Results associated with Nanjing Kanghai Phospholipid Biological Technology Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Nanjing Kanghai Phospholipid Biological Technology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Nanjing Kanghai Phospholipid Biological Technology Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 22 Sep 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
1
1
Other
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free